Hsbc Holdings PLC Purchases 14,563 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Hsbc Holdings PLC raised its position in Molina Healthcare, Inc. (NYSE:MOH) by 14.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 113,259 shares of the company’s stock after acquiring an additional 14,563 shares during the period. Hsbc Holdings PLC owned approximately 0.19% of Molina Healthcare worth $33,726,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Quent Capital LLC lifted its holdings in shares of Molina Healthcare by 6.8% during the 1st quarter. Quent Capital LLC now owns 489 shares of the company’s stock valued at $201,000 after purchasing an additional 31 shares during the last quarter. Clear Creek Financial Management LLC increased its position in Molina Healthcare by 2.2% during the 1st quarter. Clear Creek Financial Management LLC now owns 1,462 shares of the company’s stock valued at $601,000 after buying an additional 32 shares in the last quarter. Custom Index Systems LLC raised its stake in Molina Healthcare by 5.0% in the second quarter. Custom Index Systems LLC now owns 690 shares of the company’s stock valued at $205,000 after buying an additional 33 shares during the last quarter. GAMMA Investing LLC raised its stake in Molina Healthcare by 11.5% in the first quarter. GAMMA Investing LLC now owns 330 shares of the company’s stock valued at $136,000 after buying an additional 34 shares during the last quarter. Finally, AlphaMark Advisors LLC boosted its holdings in Molina Healthcare by 1.1% in the second quarter. AlphaMark Advisors LLC now owns 3,543 shares of the company’s stock worth $1,053,000 after acquiring an additional 40 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Stock Up 0.4 %

Molina Healthcare stock opened at $351.42 on Friday. The business’s 50-day moving average price is $335.60 and its 200 day moving average price is $343.44. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49. The firm has a market cap of $20.59 billion, a price-to-earnings ratio of 19.07, a price-to-earnings-growth ratio of 1.20 and a beta of 0.57. Molina Healthcare, Inc. has a 52 week low of $282.96 and a 52 week high of $423.92.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, topping analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The business had revenue of $9.88 billion for the quarter, compared to analysts’ expectations of $9.75 billion. During the same quarter last year, the company earned $5.65 EPS. The business’s revenue was up 18.7% on a year-over-year basis. As a group, sell-side analysts anticipate that Molina Healthcare, Inc. will post 23.5 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages recently commented on MOH. TD Cowen decreased their price objective on shares of Molina Healthcare from $412.00 to $351.00 and set a “buy” rating for the company in a research report on Wednesday, July 24th. JPMorgan Chase & Co. cut their price target on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 10th. Wells Fargo & Company lifted their price objective on shares of Molina Healthcare from $315.00 to $360.00 and gave the stock an “equal weight” rating in a research note on Monday, August 5th. Cantor Fitzgerald reissued an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a research report on Tuesday, September 10th. Finally, StockNews.com lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Molina Healthcare presently has an average rating of “Hold” and an average target price of $378.00.

Insider Buying and Selling at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the sale, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the transaction, the director now owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Maurice Hebert sold 393 shares of the stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.